Biotechnology News

November 8, 2012

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics Reports Third Quarter 2012 Results

November 7, 2012

DURHAM, N.C.--(BUSINESS WIRE)--CoLucid Pharmaceuticals, maker of migraine therapy lasmiditan, is attending the BIO-Europe 2012 in Hamburg, Germany

November 7, 2012

SAN FRANCISCO--(BUSINESS WIRE)--The results of a recent study presented yesterday at the American Heart Association Scientific Sessions 2012 conference in Los Angeles showed that a high-quality single-lead ECG can be quickly and easily recorded...

November 7, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the quarter ended September 30, 2012. During the quarter, Exelixis continued to advance the COMET-1 and COMET-2 phase 3 pivotal...

November 7, 2012

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) is scheduled to present at the Lazard Capital Markets 9th Annual Healthcare Conference in New York on Wednesday, November 14, 2012 at 9:30 a.m. ET and the Jefferies 2012...

November 7, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced the winners of its MiSeq grant program at the American Society of Human Genetics (ASHG) annual meeting in San Francisco. Illumina received almost 850 applications from...

November 7, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) today reported financial results for the third quarter and nine months ended September 30, 2012. The company also highlighted ADCETRIS (brentuximab vedotin) commercialization...

November 7, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Codexis, Inc. (NASDAQ: CDXS), a developer of world-leading enzymes and processes for the production of pharmaceuticals, biofuels and bio-based chemicals, today announced financial results for the third...

November 7, 2012

WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec to Present at Credit Suisse Healthcare Conference

November 7, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals (NASDAQ:ANAC) announced today its financial results for the third quarter ended September 30, 2012. “We are looking forward to announcing the results of our Phase 3 trials of tavaborole...

November 7, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced financial and operating results for the third quarter ended September 30, 2012 and other business updates. Total product revenue was $185.1 million for the...

November 7, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the third quarter ended September 30, 2012.

November 7, 2012

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Jefferies 2012 Global Healthcare Conference on Wednesday, November 14, 2012, at 9:20 a.m. GMT (4:20 a.m. EST) in...

November 7, 2012

OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (OTCBB: TBIO) today reported financial results for the three and nine months ended, September 30, 2012, and provided a business update. Third Quarter Financial Results Net sales for the third...

November 7, 2012

ARDEN HILLS, Minn.--(BUSINESS WIRE)--IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced financial results for its third quarter ended...

November 7, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm (NASDAQ:FLDM) announced it has filed litigation against NanoString Technologies, Inc. for false advertising, unfair competition, and unlawful trade practice in violation of the Lanham Act.

November 7, 2012

BOSTON--(BUSINESS WIRE)--On November 7, 2012, H&Q Healthcare Investors declared a stock distribution of $0.38 per share. The record date for the stock distribution is November 21, 2012 and the payable date is December 31, 2012. The Fund will...

November 7, 2012

NORTHWOOD, Ohio--(BUSINESS WIRE)--NAMSA, the world’s leading medical device research organization, is expanding its laboratories in Lyon, France, due to increased demand for its biocompatibility and histopathology services.

November 7, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Moberg Derma AB (OMX: MOB) today announces that it has received the final results from a phase II study of MOB-015 in patients with onychomycosis. The clinical efficacy was unsatisfactory, and the...

November 7, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca (NYSE: AZN) today announced results from a post-hoc analysis of a sub-group of the PLATO study. This new analysis evaluated outcomes in 9,946 patients with non–ST-elevation acute coronary syndrome (...

November 7, 2012

THE WOODLANDS, Texas--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (NYSE MKT: PTX), a specialty pharmaceutical company, today announced that it will release its third quarter 2012 financial results before the U.S. stock market opens on...

November 7, 2012

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb to Present at Credit Suisse Healthcare Conference

November 7, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Though more capable of long-term management, only 31% of pharmaceutical companies report dedicated lifecycle management teams, finds Cutting Edge Information study

November 7, 2012

SANTA CLARA, Calif. & PENZBERG, Germany--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) and Roche (SIX: RO, ROG) (OTCQX: RHHBY) today announced the signing of an exclusive agreement to provide continued service to NimbleGen microarray...

November 7, 2012

AARHUS, Denmark--(BUSINESS WIRE)--Today, CLC bio and the independent software vendor, BioQL, announced the release of the MedQL Variant Prioritizer plug-in for CLC Genomics Workbench. The plugin connects with MedQL’s online database to prioritize...

November 7, 2012

CHESHIRE, Conn.--(BUSINESS WIRE)--Researchers to Present Additional Data on Soliris® (eculizumab) as a Treatment for Patients with PNH and aHUS at ASH Annual Meeting

November 7, 2012

HOBOKEN, N.J.--(BUSINESS WIRE)--As part of its commitment to support the bleeding disorders community, Octapharma USA will sponsor several educational programs and present five clinical posters at the National Hemophilia Foundation’s (NHF) 64th...

November 7, 2012

WILMINGTON, N.C. & ROCHESTER, N.Y.--(BUSINESS WIRE)--Myo Technologies, LLC provider of Myotonology®, the only U.S. patented, totally non-invasive microcurrent skin toning treatment is currently being used in The Spa at Midtown – Midtown...

November 7, 2012

FARMINGTON, Conn.--(BUSINESS WIRE)--On November 14, 2012, at 4:00 p.m. EST, watch a nipple-sparing mastectomy to remove breast tissue from a patient with a family history of breast cancer, from the Baptist Health Breast Center.

November 7, 2012

OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (OTCBB: TBIO) today announced the following Webcast:     What: Transgenomic, Inc. Third Quarter 2012 Financial Results and Business Update Conference Call   When: Wednesday, November 7, 2012 @ 5:00...

November 7, 2012

NEW YORK--(BUSINESS WIRE)--Hessen will participate in the MEDICA 2012, November 14-17, 2012 in Düsseldorf. Hessen utilizes the appeal of MEDICA to present the quality of its business location and international medtech industry

November 7, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that Klaus Lindpaintner, MD, MPH, and Edison T. Liu, MD, have joined its Scientific Advisory Board. The board was...

November 7, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, today announced that Sanj K. Patel, President and Chief...

November 7, 2012

FREMONT, Calif.--(BUSINESS WIRE)--DiscoveRx today announced the acquisition of BioSeek, a drug discovery services company based in South San Francisco, California. BioSeek’s phenotypic screening technology improves the success rate of...

November 7, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that Frank Thomas, AMAG’s Chief Operating Officer, will present a company overview and business update at the Lazard Capital Markets 9th Annual Healthcare...

November 7, 2012

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Foundation, Asian-Pacific community groups share learnings on viral hepatitis management at Delivering Hope conference.

November 7, 2012

WILMINGTON, Del. & COLD SPRING HARBOR, N.Y.--(BUSINESS WIRE)--DuPont and CSHL have renewed for another 5 years of a research collaboration that began in 2007 and supports cutting-edge plant biology research focused on meeting growing food...

November 7, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--A recent Cutting Edge Information study finds that digital and mobile centers of excellence enable the development of value-based initiatives that enhance the lives of target audiences.

November 7, 2012

ALAMEDA, Calif. & JERUSALEM--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) and its subsidiary Cell Cure Neurosciences Ltd. (Cell Cure) today announced that they have entered into a share purchase agreement through which BioTime agreed to...

November 7, 2012

LOS ANGELES--(BUSINESS WIRE)--CEO and President Alan Auerbach will provide an update on cancer drug development at Puma Biotechnology on November 14 at the Lazard 9th Annual Healthcare Conference.

November 7, 2012

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Medical Imaging, Inc. (“Lantheus”) today announced that it will host a conference call at 4:00 p.m. ET on Tuesday, November 13, 2012 to discuss its financial and operating results for the third...

November 7, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE MKT: SNT) reported today that the clinical trial of SNS01-T has been expanded to include diffuse large B-cell lymphoma (DLBCL) and mantle cell...

November 7, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA) announced today that interim results from the Phase 2b/3 GALAXY trial will be presented at the Chemotherapy Foundation Symposium in New York City on Friday, November 9...

November 7, 2012

ALACHUA, Fla.--(BUSINESS WIRE)--AxoGen, Inc. (OTCBB: AXGN), a leading regenerative medicine company dedicated to advancing the science and commercialization of peripheral nerve repair solutions, today announced revenues for the third quarter...

November 7, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--Shinagawa LASIK Center, the largest LASIK center in Japan, has acquired TearScience's system to better serve its patients who suffer from evaporative dry eye.

November 7, 2012

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) today announced its presentations at two upcoming investor conferences will be webcast live and will be available in the investor relations section of the company’s web site at...

November 7, 2012

WOBURN, Mass.--(BUSINESS WIRE)--ArQule announces upcoming presentation at Lazard Healthcare Conference on November 14, 2012.

November 7, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today reported financial results for the third quarter and nine months ended September 30, 2012 and provided an update on corporate developments. “We are advancing the...